Literature DB >> 6219952

Analysis of cell wall and membrane contamination of ribosomal preparations from Streptococcus mutans.

R L Gregory, I L Shechmeister.   

Abstract

A ribosomal preparation from a cariogenic strain of Streptococcus mutans was examined for cell wall and membrane contamination. A biochemical characterization established that the preparation contained 61.0% RNA and 39.0% protein. Carbohydrate was not detected by phenol-sulfuric acid or methyl pentose assays. Glucosyltransferase and D-succinate dehydrogenase, which are cell wall- and membrane-associated enzymes, respectively, were not found. However, D-lactate dehydrogenase, another membrane-associated enzyme, was present in the preparation. A comparison of two-dimensional gel electropherograms of a mixture of cell walls and membranes and the S. mutans ribosomal preparation revealed contamination of the latter sample with at least six cell wall- or membrane-associated proteins. Adsorption of a rabbit antiserum raised against the ribosomal preparation with whole S. mutans cells abrogated antibodies directed against at least two proteins from the ribosomal preparation. Immunodiffusion plates showed reactivity of this antiserum against preparations of purified lipoteichoic acid from Streptococcus pyogenes and S. mutans. Adsorption of rat and rabbit antisera against the ribosomal preparation with the cell wall-derived materials glucosyltransferase, lipoteichoic acid, glucan, and a Rantz-Randall extract reduced the concentration of antibodies against the ribosomes by as much as 10-fold. These data indicated that the preparation was contaminated with at least six cell wall proteins, one cell membrane-associated enzyme, and lipoteichoic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219952      PMCID: PMC348021          DOI: 10.1128/iai.39.2.807-816.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Qualitative and quantitative colorimetric determination of heptoses.

Authors:  Z DISCHE
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

4.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

5.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

6.  Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations.

Authors:  R Jensen; B Gregory; J Naylor; P Actor
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

7.  Role of outer envelope contamination in protection elicited by ribosomal preparations against Neisseria gonorrhoeae infection.

Authors:  M D Cooper; M J Wannemuehler; R D Miller; M F Fedyk
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

9.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.

Authors:  M M Riottot; J M Fournier; H Jouin
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more
  5 in total

Review 1.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

2.  Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes.

Authors:  R L Gregory; S M Michalek; G Richardson; C Harmon; T Hilton; J R McGhee
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

3.  Lack of cross-reactivity of antibodies to ribosomal preparations from Streptococcus mutans with human heart and kidney antigens.

Authors:  R L Gregory; I L Shechmeister; J O Brubaker; C T Smedberg; S M Michalek; J R McGhee
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

4.  Salivary immunoglobulin A and serum antibodies to Streptococcus mutans ribosomal preparations in dental caries-free and caries-susceptible human subjects.

Authors:  R L Gregory; S J Filler; S M Michalek; J R McGhee
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

5.  Function of anti-Streptococcus mutans antibodies: anti-ribosomal antibodies inhibit acid production, growth, and glucose phosphotransferase activity.

Authors:  R L Gregory; S M Michalek; I L Shechmeister; J R McGhee
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.